1. Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care. (3rd September 2018) Authors: Glintborg, B; Kringelbach, T; Bolstad, N; Warren, DJ; Eng, G; Sørensen, IJ; Loft, AG; Hendricks, O; Hansen, IMJ; Linauskas, A; Nordin, H; Kristensen, S; Lindegaard, H; Jensen, DV; Goll, GL; Høgdall, E; Gehin, J; Enevold, C; Nielsen, CH; Krogh, NS Journal: Scandinavian journal of rheumatology Issue: Volume 47:Number 5(2018) Page Start: 418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗